BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27023678)

  • 1. Thiobarbituric Acid-Reactive Substances: Markers of an Acute Episode and a Late Stage of Bipolar Disorder.
    Siwek M; Sowa-Kucma M; Styczen K; Misztak P; Szewczyk B; Topor-Madry R; Nowak G; Dudek D; Rybakowski JK
    Neuropsychobiology; 2016; 73(2):116-22. PubMed ID: 27023678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia.
    Kunz M; Gama CS; Andreazza AC; Salvador M; Ceresér KM; Gomes FA; Belmonte-de-Abreu PS; Berk M; Kapczinski F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1677-81. PubMed ID: 18657586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts.
    Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():372-383. PubMed ID: 28867391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in early stage Bipolar Disorder and the association with response to lithium.
    de Sousa RT; Zarate CA; Zanetti MV; Costa AC; Talib LL; Gattaz WF; Machado-Vieira R
    J Psychiatr Res; 2014 Mar; 50():36-41. PubMed ID: 24332923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiobarbituric acid reactive substances (TBARS) is a state biomarker of oxidative stress in bipolar patients in a manic phase.
    Tsai MC; Huang TL
    J Affect Disord; 2015 Mar; 173():22-6. PubMed ID: 25462391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder--Gender and obesity effects.
    Bengesser SA; Lackner N; Birner A; Fellendorf FT; Platzer M; Mitteregger A; Unterweger R; Reininghaus B; Mangge H; Wallner-Liebmann SJ; Zelzer S; Fuchs D; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    J Affect Disord; 2015 Feb; 172():367-74. PubMed ID: 25451439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased serum zinc concentration during depressive episode in patients with bipolar disorder.
    Siwek M; Sowa-Kućma M; Styczeń K; Szewczyk B; Reczyński W; Misztak P; Topór-Mądry R; Nowak G; Dudek D; Rybakowski JK
    J Affect Disord; 2016 Jan; 190():272-277. PubMed ID: 26540081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects.
    Machado-Vieira R; Andreazza AC; Viale CI; Zanatto V; Cereser V; da Silva Vargas R; Kapczinski F; Portela LV; Souza DO; Salvador M; Gentil V
    Neurosci Lett; 2007 Jun; 421(1):33-6. PubMed ID: 17548157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects.
    Gubert C; Stertz L; Pfaffenseller B; Panizzutti BS; Rezin GT; Massuda R; Streck EL; Gama CS; Kapczinski F; Kunz M
    J Psychiatr Res; 2013 Oct; 47(10):1396-402. PubMed ID: 23870796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls.
    Jiménez-Fernández S; Gurpegui M; Garrote-Rojas D; Gutiérrez-Rojas L; Carretero MD; Correll CU
    Bipolar Disord; 2021 Mar; 23(2):117-129. PubMed ID: 32780547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Oxidative Stress Markers in Patients with Bipolar Disorder during Euthymia and in Siblings.
    Tatay-Manteiga A; Balanzá-Martínez V; Bristot G; Tabarés-Seisdedos R; Kapczinski F; Cauli O
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):77-86. PubMed ID: 30848220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased uric acid levels in bipolar disorder: is it trait or state?
    Kesebir S; Süner O; Yaylaci ET; Bayrak A; Turan C
    J Biol Regul Homeost Agents; 2013; 27(4):981-8. PubMed ID: 24382179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum S100B and antioxidant enzymes in bipolar patients.
    Andreazza AC; Cassini C; Rosa AR; Leite MC; de Almeida LM; Nardin P; Cunha AB; Ceresér KM; Santin A; Gottfried C; Salvador M; Kapczinski F; Gonçalves CA
    J Psychiatr Res; 2007 Sep; 41(6):523-9. PubMed ID: 16956621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder.
    Scola G; McNamara RK; Croarkin PE; Leffler JM; Cullen KR; Geske JR; Biernacka JM; Frye MA; DelBello MP; Andreazza AC
    J Affect Disord; 2016 Mar; 192():176-83. PubMed ID: 26735329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serum concentration of copper in bipolar disorder.
    Siwek M; Styczeń K; Sowa-Kućma M; Dudek D; Reczyński W; Szewczyk B; Misztak P; Opoka W; Topór-Mądry R; Nowak G; Rybakowski JK
    Psychiatr Pol; 2017 Jun; 51(3):469-481. PubMed ID: 28866717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia.
    Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
    Neurotox Res; 2018 Feb; 33(2):448-460. PubMed ID: 29103192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress markers in bipolar disorder: a meta-analysis.
    Andreazza AC; Kauer-Sant'anna M; Frey BN; Bond DJ; Kapczinski F; Young LT; Yatham LN
    J Affect Disord; 2008 Dec; 111(2-3):135-44. PubMed ID: 18539338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity.
    Pedrini M; Massuda R; Fries GR; de Bittencourt Pasquali MA; Schnorr CE; Moreira JC; Teixeira AL; Lobato MI; Walz JC; Belmonte-de-Abreu PS; Kauer-Sant'Anna M; Kapczinski F; Gama CS
    J Psychiatr Res; 2012 Jun; 46(6):819-24. PubMed ID: 22520512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder.
    Banerjee U; Dasgupta A; Rout JK; Singh OP
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):56-61. PubMed ID: 22230647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.